Personalis Inc share price today

(PSNL)

Personalis Inc share price is $3.89 & ₹329.42

$3.89

▲

-0.01

(-0.26%)

Market is closed - opens 8 PM, 04 Dec 2024

View live Personalis Inc share price in Dollar and Rupees. Guide to invest in Personalis Inc from India. Also see the sentimental analysis on Indian investors investing in Personalis Inc. Get details on the Indian mutual funds that are investing in Personalis Inc. Get Analyst recommendations and forecasts along with all the Personalis Inc's financials.

Personalis Inc share price movements

$3.85
$3.99
$3.89
1.03%
Downside
Day's Volatility :3.51%
Upside
2.51%
$1.12
$7.20
$3.89
71.21%
Downside
52 Weeks Volatility :84.44%
Upside
45.97%

Personalis Inc Returns

Period	Personalis Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-27.64%	-6.2%	0.0%
6 Months	165.31%	1.7%	0.0%
1 Year	150.0%	11.6%	0.0%
3 Years	-69.72%	12.9%	-18.1%

Personalis Inc Key Statistics

in dollars & INR

Market Capitalization	$280.5M
Revenue TTM	$87.5M
EBITDA	$-58.8M
Earnings Per Share (EPS)	$-1.73
Profit Margin	-104.52%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-57.52%

How to invest in Personalis Inc from India?

It is very easy for Indian residents to invest directly in Personalis Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Personalis Inc stock in both rupees (INR) and dollars (USD). Search for Personalis Inc or PSNL on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Personalis Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Personalis Inc shares which would translate to 0.218 fractional shares of Personalis Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Personalis Inc

23%

Period: Sep 4, 2024 to Dec 3, 2024. Change in 30 Days versus previous period

Search volume for Personalis Inc on INDmoney from India has grown in the last 30 days as on Dec 4, 2024. 23% more investors are searching Personalis Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Personalis Inc

ARK Investment Management LLC
10.03%
AIGH Capital Management, LLC
5.66%
BlackRock Inc
4.66%
Millennium Management LLC
3.45%
Vanguard Group Inc
2.79%
Blue Water Life Science Advisors, LLC
1.42%

Analyst Recommendation on Personalis Inc

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Personalis Inc(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Personalis Inc

What analysts predicted

Upside of 80.46%

Current:

$3.89

Target:

$7.02

Insights on Personalis Inc

Increasing Revenue
Revenue is up for the last 3 quarters, 19.52M → 25.70M (in $), with an average increase of 12.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -12.80M → -39.08M (in $), with an average decrease of 205.3% per quarter
Vs A
In the last 3 years, Personalis Inc has experienced a drawdown of -68.1%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 61.6%

Personalis Inc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$37.8M	↑ 302.15%
Net Income	$-19.9M	↓ 15.73%
Net Profit Margin	-52.64%	↑ 198.59%

	FY19	Y/Y Change
Revenue	$65.2M	↑ 72.62%
Net Income	$-25.1M	↑ 26.14%
Net Profit Margin	-38.47%	↑ 14.17%

	FY20	Y/Y Change
Revenue	$78.6M	↑ 20.61%
Net Income	$-41.3M	↑ 64.57%
Net Profit Margin	-52.49%	↓ 14.02%

	FY21	Y/Y Change
Revenue	$85.5M	↑ 8.7%
Net Income	$-65.2M	↑ 58.01%
Net Profit Margin	-76.29%	↓ 23.8%

	FY22	Y/Y Change
Revenue	$65.0M	↓ 23.92%
Net Income	$-113.3M	↑ 73.73%
Net Profit Margin	-174.2%	↓ 97.91%

	FY23	Y/Y Change
Revenue	$73.5M	↑ 12.97%
Net Income	$-108.3M	↓ 4.43%
Net Profit Margin	-147.38%	↑ 26.82%

	Q2 FY23	Q/Q Change
Revenue	$16.7M	↓ 11.46%
Net Income	$-24.0M	↓ 16.41%
Net Profit Margin	-143.45%	↑ 8.51%

	Q3 FY23	Q/Q Change
Revenue	$18.2M	↑ 9.27%
Net Income	$-29.1M	↑ 21.47%
Net Profit Margin	-159.47%	↓ 16.02%

	Q4 FY23	Q/Q Change
Revenue	$19.7M	↑ 7.83%
Net Income	$-26.6M	↓ 8.64%
Net Profit Margin	-135.12%	↑ 24.35%

	Q1 FY24	Q/Q Change
Revenue	$19.5M	↓ 0.76%
Net Income	$-13.0M	↓ 51.22%
Net Profit Margin	-66.42%	↑ 68.7%

	Q2 FY24	Q/Q Change
Revenue	$22.6M	↑ 15.65%
Net Income	$-12.8M	↓ 1.28%
Net Profit Margin	-56.7%	↑ 9.72%

	Q3 FY24	Q/Q Change
Revenue	$25.7M	↑ 13.86%
Net Income	$-39.1M	↑ 205.34%
Net Profit Margin	-152.04%	↓ 95.34%

	FY18	Y/Y Change
Total Assets	$41.7M	↑ 24.15%
Total Liabilities	$148.1M	↑ 17.35%

	FY19	Y/Y Change
Total Assets	$157.3M	↑ 277.47%
Total Liabilities	$50.6M	↓ 65.82%

	FY20	Y/Y Change
Total Assets	$244.8M	↑ 55.66%
Total Liabilities	$49.9M	↓ 1.39%

	FY21	Y/Y Change
Total Assets	$396.5M	↑ 61.95%
Total Liabilities	$86.2M	↑ 72.81%

	FY22	Y/Y Change
Total Assets	$292.7M	↓ 26.18%
Total Liabilities	$74.6M	↓ 13.53%

	FY23	Y/Y Change
Total Assets	$225.1M	↓ 23.1%
Total Liabilities	$95.7M	↑ 28.29%

	Q2 FY23	Q/Q Change
Total Assets	$249.0M	↓ 8.5%
Total Liabilities	$73.0M	↓ 7.12%

	Q3 FY23	Q/Q Change
Total Assets	$226.6M	↓ 9.0%
Total Liabilities	$75.4M	↑ 3.4%

	Q4 FY23	Q/Q Change
Total Assets	$225.1M	↓ 0.68%
Total Liabilities	$95.7M	↑ 26.82%

	Q1 FY24	Q/Q Change
Total Assets	$195.3M	↓ 13.25%
Total Liabilities	$74.6M	↓ 22.03%

	Q2 FY24	Q/Q Change
Total Assets	$185.5M	↓ 5.01%
Total Liabilities	$73.2M	↓ 1.81%

	Q3 FY24	Q/Q Change
Total Assets	$239.9M	↑ 29.32%
Total Liabilities	$73.1M	↓ 0.14%

	FY18	Y/Y Change
Operating Cash Flow	$5.6M	↑ 1821.38%
Investing Cash Flow	$-7.9M	↑ 52.23%
Financing Cash Flow	$-591.0K	↓ 103.6%

	FY19	Y/Y Change
Operating Cash Flow	$-18.1M	↓ 424.28%
Investing Cash Flow	$-81.6M	↑ 938.96%
Financing Cash Flow	$134.9M	↓ 22933.84%

	FY20	Y/Y Change
Operating Cash Flow	$-42.7M	↑ 136.06%
Investing Cash Flow	$-65.1M	↓ 20.15%
Financing Cash Flow	$121.3M	↓ 10.14%

	FY21	Y/Y Change
Operating Cash Flow	$-70.8M	↑ 66.06%
Investing Cash Flow	$-60.1M	↓ 7.79%
Financing Cash Flow	$169.7M	↑ 39.94%

	FY22	Y/Y Change
Operating Cash Flow	$-70.2M	↓ 0.84%
Investing Cash Flow	$52.5M	↓ 187.46%
Financing Cash Flow	$1.4M	↓ 99.2%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-10.4M	↓ 33.86%
Investing Cash Flow	$19.5M	↑ 41.73%
Financing Cash Flow	$925.0K	↑ 0.0%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-16.7M	↑ 60.18%
Investing Cash Flow	$-8.6M	↓ 144.02%
Financing Cash Flow	$290.0K	↓ 68.65%

Personalis Inc Technicals Summary

Sell

Neutral

Buy

Personalis Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Personalis Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Personalis Inc	-22.0%	165.31%	150.0%	-69.72%	-58.51%
Idexx Laboratories, Inc.	3.92%	-13.12%	-16.99%	-27.26%	71.37%
Agilent Technologies Inc.	-0.05%	4.51%	9.15%	-7.85%	69.78%
Thermo Fisher Scientific, Inc.	-4.59%	-7.88%	7.8%	-14.83%	65.55%
Danaher Corp.	-2.38%	-9.92%	9.96%	-21.38%	62.79%
Iqvia Holdings Inc.	-4.0%	-7.82%	-5.84%	-23.3%	35.89%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Personalis Inc	NA	NA	NA	-1.45	-0.58	-0.19	NA	2.36
Idexx Laboratories, Inc.	40.63	40.63	4.44	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	31.14	31.14	2.34	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	33.23	33.23	2.02	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	45.22	45.22	3.2	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.47	26.47	1.04	11.13	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Personalis Inc	Buy	$280.5M	-58.51%	NA	-104.52%
Idexx Laboratories, Inc.	Buy	$34.5B	71.37%	40.63	22.53%
Agilent Technologies Inc.	Buy	$39.4B	69.78%	31.14	21.75%
Thermo Fisher Scientific, Inc.	Buy	$202.6B	65.55%	33.23	14.48%
Danaher Corp.	Buy	$173.1B	62.79%	45.22	16.39%
Iqvia Holdings Inc.	Buy	$36.6B	35.89%	26.47	9.17%

About Personalis Inc

personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.

Organization	Personalis Inc
Employees	223
CEO	Mr. Christopher M. Hall
Industry	Biotechnology

Important FAQs about investing in Personalis Inc from India :

What is Personalis Inc share price today?

Personalis Inc (PSNL) share price today is $3.89.

Can Indians buy Personalis Inc shares?

Yes, Indians can invest in the Personalis Inc (PSNL) from India.

With INDmoney, you can buy Personalis Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Personalis Inc at zero transaction cost.

How can I buy Personalis Inc shares from India?

It is very easy to buy Personalis Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Personalis Inc be purchased?

Yes, you can buy fractional shares of Personalis Inc with INDmoney app.

What are the documents required to start investing in Personalis Inc stocks?

To start investing in Personalis Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.